Diallyl sulfide protects against N-nitrosodiethylamine-induced liver tumorigenesis: Role of aldose reductase

World Journal of Gastroenterology

Volumn 14, Issue 40, 2008, Pages 6145-6153

  Ibrahim, Safinaz S ^a   Nassar, Noha N ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Aldose reductase; Diallyl sulfide; Energy metabolism; Liver cancer; N nitrosodiethylamine

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALDEHYDE REDUCTASE; ALLYL SULFIDE; CATALASE; CYTOCHROME C OXIDASE; DIETHYLNITROSAMINE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; LACTATE DEHYDROGENASE; LACTIC ACID; MALONALDEHYDE; NITRIC OXIDE; PYRUVIC ACID; SUPEROXIDE DISMUTASE; ALLYL COMPOUND; ANTINEOPLASTIC AGENT; ANTIOXIDANT; REACTIVE OXYGEN METABOLITE; SULFIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER RESISTANCE; CONTROLLED STUDY; DNA FRAGMENTATION; ENERGY METABOLISM; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER FUNCTION; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; ANIMAL; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; DNA DAMAGE; DRUG EFFECT; ENZYMOLOGY; LIVER; LIVER TUMOR; METABOLISM; PATHOLOGY; WISTAR RAT;

ALDEHYDE REDUCTASE; ALLYL COMPOUNDS; ANIMALS; ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; CELL TRANSFORMATION, NEOPLASTIC; DIETHYLNITROSAMINE; DNA DAMAGE; ENERGY METABOLISM; LIPID PEROXIDATION; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SULFIDES;

EID: 63449132720     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.6145     Document Type: Article

References (58)

1. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr. International trends and patterns of primary liver cancer. Int J Cancer 2001; 94: 290-296
2. D'Alessandro N, Poma P, Montalto G. Multifactorial nature of hepatocellular carcinoma drug resistance: could plant polyphenols be helpful? World J Gastroenterol 2007; 13: 2037-2043
3. Steiner M, Seule M, Steiner B, Bauer I, Freund M, Kohne CH, Schuff-Werner P. 5-Fluorouracil/irinotecan induced lethal toxicity as a result of a combined pharmacogenetic syndrome: report of a case. J Clin Pathol 2005; 58: 553-555
4. Schorah CJ. Micronutrients, vitamins, and cancer risk. Vitam Horm 1999; 57: 1-23
5. Singh SV, Mohan RR, Agarwal R, Benson PJ, Hu X, Rudy MA, Xia H, Katoh A, Srivastava SK, Mukhtar H, Gupta V, Zaren HA. Novel anti-carcinogenic activity of an organosulfide from garlic: inhibition of H-RAS oncogene transformed tumor growth in vivo by diallyl disulfide is associated with inhibition of p21H-ras processing. Biochem Biophys Res Commun 1996; 225: 660-665
6. Agarwal KC. Therapeutic actions of garlic constituents. Med Res Rev 1996; 16: 111-124
7. Aquilano K, Filomeni G, Baldelli S, Piccirillo S, De Martino A, Rotilio G, Ciriolo MR. Neuronal nitric oxide synthase protects neuroblastoma cells from oxidative stress mediated by garlic derivatives. J Neurochem 2007; 101: 1327-1337
8. Shukla Y, Kalra N. Cancer chemoprevention with garlic and its constituents. Cancer Lett 2007; 247: 167-181
9. Jakubikova J, Sedlak J. Garlic-derived organosulfides induce cytotoxicity, apoptosis, cell cycle arrest and oxidative stress in human colon carcinoma cell lines. Neoplasma 2006; 53: 191-199
10. Arunkumar A, Vijayababu MR, Venkataraman P, Senthilkumar K, Arunakaran J. Chemoprevention of rat prostate carcinogenesis by diallyl disulfide, an organosulfur compound of garlic. Biol Pharm Bull 2006; 29: 375-379
11. El-Bayoumy K, Sinha R, Pinto JT, Rivlin RS. Cancer chemoprevention by garlic and garlic-containing sulfur and selenium compounds. J Nutr 2006; 136: 864S-869S
12. Herman-Antosiewicz A, Singh SV. Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review. Mutat Res 2004; 555: 121-131
13. Weichselbaum TE, Varney PL. A new method of flame photometry. Proc Soc Exp Biol Med 1949; 71: 570-572
14. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 1971; 31: 87-96
15. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957; 28: 56-63
16. Kind PR, King EJ. Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine. J Clin Pathol 1954; 7: 322-326
17. Belfield A, Goldberg DM. Colorimetric determination of alkaline phosphatase activity. Enzyme 1971; 12: 561-568
18. Szasz G. A kinetic photometric method for serum gamma-glutamyl transpeptidase. Clin Chem 1969; 15: 124-136
19. Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol 1979; 135: 372-376
20. Smith L. Spectrophotometric assay of cytochrome c oxidase. In Methods of Biochemical Analysis. In: Glick D ed. New York: John Wiley & Sons, 1955: 427-434
21. Schmidt HH, Warner TD, Nakane M, Forstermann U, Murad F. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol Pharmacol 1992; 41: 615-624
22. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139
23. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-474
24. Buhl SN, Jackson KY. Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate-to-lactate reactions in human serum at 25, 30, and 37 degrees C. Clin Chem 1978; 24: 828-831
25. Sie HG, Hablanian A, Fishman WH. Divergent effects of actinomycin d on cortisol and on glucose stimulation of glycogenesis in mouse liver. Biochem J 1967; 102: 103-109
26. Maral J, Puget K, Michelson AM. Comparative study of superoxide dismutase, catalase and glutathione peroxidase levels in erythrocytes of different animals. Biochem Biophys Res Commun 1977; 77: 1525-1535
27. Mohun AF, Cook IJ. Simple methods for measuring serum levels of the glutamic-oxalacetic and glutamic-pyruvic transaminases in routine laboratories. J Clin Pathol 1957; 10: 394-399
28. David BS. Carbohydrate. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry, 3rd ed. Philadelphia, Pennsylvania: W.B. Saunders Company, 1999: 788
29. Lowry OH, Passommeau JV, Hasselberger FX, Schulz DW. Effect of Ischemia on Known Substrates and Cofactors of the Glycolytic Pathway in Brain. J Biol Chem 1964; 239: 18-30
30. Harper AE. Hormonal factors affecting glucose 6-phosphatase activity. 2. Some effects of diet and of alloxan diabetes in the rat. Biochem J 1959; 71: 702-705
31. Giles KW, Myers A. An imporoved diphenylamine method for the estimation of deoxyribonucleic acid. Nature (Lond) 1965; 206: 93
32. Chauncey B, Leite MV, Goldstein L. Renal sorbitol accumulation and associated enzyme activities in diabetes. Enzyme 1988; 39: 231-234
33. Lowry OH, Rosebrough NJ, Farr AL, Ranall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
34. Dakshayani KB, Subramanian P, Manivasagam T, Essa MM, Manoharan S. Melatonin modulates the oxidant-antioxidant imbalance during N-nitrosodiethylamine induced hepatocarcinogenesis in rats. J Pharm Pharm Sci 2005; 8: 316-321
35. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006; 43: S31-S44
36. Winzer K, Van Noorden CJ, Kohler A. Glucose-6-phosphate dehydrogenase: the key to sex-related xenobiotic toxicity in hepatocytes of European flounder (Platichthys flesus L.)? Aquat Toxicol 2002; 56: 275-288
37. Frederiks WM, Bosch KS, De Jong JS, Van Noorden CJ. Post-translational regulation of glucose-6-phosphate dehydrogenase activity in (pre)neoplastic lesions in rat liver. J Histochem Cytochem 2003; 51: 105-112
38. Kletzien RF, Harris PK, Foellmi LA. Glucose-6-phosphate dehydrogenase: a "housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J 1994; 8: 174-181
39. Ninfali P, Biagiotti E, Guidi L, Malatesta M, Gazzanelli G, Del Grande P. Cytochemical and immunocytochemical methods for electron microscopic detection of glucose-6-phosphate dehydrogenase in brain areas. Brain Res Brain Res Protoc 2000; 5: 115-120
40. Spolarics Z. Endotoxemia, pentose cycle, and the oxidant/ antioxidant balance in the hepatic sinusoid. J Leukoc Biol 1998; 63: 534-541
41. Salati LM, Amir-Ahmady B. Dietary regulation of expression of glucose-6-phosphate dehydrogenase. Annu Rev Nutr 2001; 21: 121-140
42. Kuo W, Lin J, Tang TK. Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice. Int J Cancer 2000; 85: 857-864
43. Biagiotti E, Bosch KS, Ninfali P, Frederiks WM, Van Noorden CJ. Posttranslational regulation of glucose-6-phosphate dehydrogenase activity in tongue epithelium. J Histochem Cytochem 2000; 48: 971-977
44. Rajkapoor B, Murugesh N, Chodon D, Sakthisekaran D. Chemoprevention of N-nitrosodiethylamine induced phenobarbitol promoted liver tumors in rat by extract of Indigofera aspalathoides. Biol Pharm Bull 2005; 28: 364-366
45. Milner JA. Preclinical perspectives on garlic and cancer. J Nutr 2006; 136: 827S-831S
46. Yang SS, Huang CC, Chen JR, Chiu CL, Shieh MJ, Lin SJ, Yang SC. Effects of ethanol on antioxidant capacity in isolated rat hepatocytes. World J Gastroenterol 2005; 11: 7272-7276
47. Manna PR, Chandrala SP, King SR, Jo Y, Counis R, Huhtaniemi IT, Stocco DM. Molecular mechanisms of insulin-like growth factor-I mediated regulation of the steroidogenic acute regulatory protein in mouse leydig cells. Mol Endocrinol 2006; 20: 362-378
48. Park YJ, Choi EY, Choi JY, Park JG, You HJ, Chung MH. Genetic changes of hOGG1 and the activity of oh8Gua glycosylase in colon cancer. Eur J Cancer 2001; 37: 340-346
49. Sundaresan S, Subramanian P. S-allylcysteine inhibits circulatory lipid peroxidation and promotes antioxidants in N-nitrosodiethylamine-induced carcinogenesis. Pol J Pharmacol 2003; 55: 37-42
50. Park KA, Kweon S, Choi H. Anticarcinogenic effect and modification of cytochrome P450 2E1 by dietary garlic powder in diethylnitrosamine-initiated rat hepatocarcinogenesis. J Biochem Mol Biol 2002; 35: 615-622
51. van Schaftingen E, Gerin I. The glucose-6-phosphatase system. Biochem J 2002; 362: 513-532
52. Singh A, Arora A, Shukla Y. Modulation of altered hepatic foci induction by diallyl sulphide in Wistar rats. Eur J Cancer Prev 2004; 13: 263-269
53. Xiao D, Pinto JT, Gundersen GG, Weinstein IB. Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells. Mol Cancer Ther 2005; 4: 1388-1398
54. Rotem R, Heyfets A, Fingrut O, Blickstein D, Shaklai M, Flescher E. Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria. Cancer Res 2005; 65: 1984-1993
55. You KR, Wen J, Lee ST, Kim DG. Cytochrome c oxidase subunit III: a molecular marker for N-(4-hydroxyphenyl) retinamise-induced oxidative stress in hepatoma cells. J Biol Chem 2002; 277: 3870-3877
56. Saraswat M, Mrudula T, Kumar PU, Suneetha A, Rao Rao TS, Srinivasulu M, Reddy B. Overexpression of aldose reductase in human cancer tissues. Med Sci Monit 2006; 12: CR525-CR529
57. Zeindl-Eberhart E, Haraida S, Liebmann S, Jungblut PR, Lamer S, Mayer D, Jager G, Chung S, Rabes HM. Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas. Hepatology 2004; 39: 540-549
58. Thomas T, Rauscher F, Sanders R, Veltman J, Watkins JB 3rd. Effects of aldose reductase inhibitors on antioxidant defense in rat and rabbit liver. Toxicol Sci 2000; 53: 145-149